The role of data and safety monitoring boards in implementation trials: When are they justified?

The National Institutes of Health requires data and safety monitoring boards (DSMBs) for all phase III clinical trials. The National Heart, Lung and Blood Institute requires DSMBs for all clinical trials involving more than one site and those involving cooperative agreements and contracts. These pol...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiscella, Kevin, Sanders, Mechelle, Holder, Tameir, Carroll, Jennifer K., Luque, Amneris, Cassells, Andrea, Johnson, Brent A., Williams, Stephen K., Tobin, Jonathan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Special Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348012/
https://www.ncbi.nlm.nih.gov/pubmed/32695494
http://dx.doi.org/10.1017/cts.2020.19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348012/
https://www.ncbi.nlm.nih.gov/pubmed/32695494
http://dx.doi.org/10.1017/cts.2020.19

Ejemplares similares